According to the 2023 Canadian Thoracic Society guidelines on pharmacotherapy in patients
with stable COPD, all the following statements are true, EXCEPT for . . .
The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.
With pharmacists also able to prescribe, patients have more access to birth control—but high demand is also leading to long waits for procedures like IUD insertion.